Beta measures a stock's volatility in comparison to the overall market. By definition, the market, such as the S&P 500 Index, has a beta of 1.0. A beta above 1.0 suggests a stock is more volatile than the broader market, and a beta below 1.0 indicates the opposite. Low-beta stocks can provide several beneficial advantages for portfolios, including defensive qualities. They can also offer stabilization when combined with high-beta stocks, helping to give a more balanced risk profile. Three low-beta stocks – Interactive Brokers IBKR, Elevance Health ELV, and Consolidated Edison ED – could all be considered for those looking for a more conservative approach. In addition to decreased volatility, all three sport a favorable Zacks Rank, reflecting optimism among analysts. Let’s take a closer look at each. Elevance Health Keeps Beating Earnings Expectations Elevance Health operates as a health benefits company, supporting consumers, families, and communities throughout the care journey to lead healthier lives. The company sports a favorable Zacks Rank #2 (Buy), with earnings expectations inching higher nearly across the board. ELV’s latest quarterly results pleased investors, with shares moving well higher after the earnings release. Regarding headline figures, Elevance posted a 1% beat relative to the Zacks Consensus EPS estimate and reported sales modestly below expectations. Earnings grew 12.5% year over year, whereas sales increased 1%. Below is a chart illustrating the company’s quarterly revenue. Zacks Investment Research Image Source: Zacks Investment Research Interactive Brokers Crushes S&P 500 Interactive Brokers Group operates as an automated global electronic market maker and broker. Analysts have positively revised expectations across the board, landing the stock into a favorable Zacks Rank #2 (Buy). Zacks Investment Research Image Source: Zacks Investment Research It’s worth noting that the stock is a big-time outperformer over the last two years, adding an impressive 125% in value compared to the S&P 500’s 50% gain. Increased trading activity has benefited the company nicely over recent years. Zacks Investment Research Image Source: Zacks Investment Research Consolidated Edison Keeps Rewarding Shareholders Consolidated Edison, a current Zacks Rank #2 (Buy), is a diversified utility holding company with subsidiaries engaged in both regulated and unregulated businesses. The company has been a great earnings performer, exceeding the Zacks Consensus EPS estimate by an average of 6% across its last four releases. Income-focused investors could find ED shares attractive, currently yielding a solid 3.8% annually. Dividend growth is also apparent, with the company sporting a modest 2% five-year annualized dividend growth rate. The company has long displayed a shareholder-friendly nature, as we can see illustrated below. Zacks Investment Research Image Source: Zacks Investment Research Bottom Line Low-beta stocks can provide several beneficial advantages for portfolios, including defensive qualities. They can also offer stabilization when combined with high-beta stocks, helping to give a more balanced risk profile. And for those seeking a more conservative approach, all three low-beta stocks above - Interactive Brokers IBKR, Elevance Health ELV, and Consolidated Edison ED – could be considerations. In addition to decreased volatility, all three sport favorable Zacks Ranks, reflecting optimism among analysts. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Consolidated Edison Inc (ED):Free Stock Analysis Report Interactive Brokers Group, Inc. (IBKR):Free Stock Analysis Report Elevance Health, Inc. (ELV):Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research
Tame Volatility with These 3 Low Beta Stocks
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...